Purchase Order VA24117P0611
Award Date 1/12/17
Potential Completion Date 2/17/17
Potential Value $76K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $75,208.70, is for the provision of the pharmaceutical product LEMTRADA. The contract has an ultimate completion date of October 26, 2016 and was awarded on October 21, 2016. This contract is not a set-aside award and was open to all qualified vendors....
- This federal contract award, with an ID of 36C24225P0094, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, doing business as Walgreens, as the prime contractor. The $12,580.72 firm fixed price purchase order is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to VA facilities. Walgreens Specialty Pharmacy, a for-profit organization, has been providing specialized pharmaceutical...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the emergency procurement of the medication Jynarque (tolvaptan) to support the VA's healthcare services for veterans. The contract has a period of performance through July 7, 2025 and does not have a set-aside designation,...
- The Department of Veterans Affairs Veterans Health Administration awarded Walgreens Specialty Pharmacy, LLC a $12,224.60 firm fixed price purchase order under the Veterans Integrated Service Network 2 vehicle to deliver JYNARQUE 45MG/15MG tablets from July 6, 2023 through October 6, 2023. Walgreens Specialty Pharmacy, LLC will perform from its location in Pittsburgh, Pennsylvania to supply the requested pharmaceutical products in support of VHA's mission to provide healthcare services to...
- This federal contract award, with an ID of 36C24225P0469, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The $13,242.99 firm fixed-price purchase order is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets. This award does not have a set-aside designation, meaning it was open to all qualified vendors. The contract has an...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Walgreens Specialty Pharmacy, LLC in the amount of $12,580.72. The contract is for the delivery of the medication Jynarque (tolvaptan) to treat autosomal dominant polycystic kidney disease. This contract was awarded to Walgreens Specialty Pharmacy as the prime contractor, with no set-aside designation mentioned. The contract period of performance runs through March 19,...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to the VA's Veterans Integrated Service Network (VISN) 2. The contract is not set aside for any specific business type, and there are no indications of subcontractors....
- This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
- This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government, with a focus on supporting the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, which is fulfilling this $1,164.26 firm fixed price delivery order through its Corporate Office division. The contract has no set-aside designation and was awarded on a full and...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the larger Walgreens retail pharmacy chain. The contract, valued at $75,582.75, is for the supply of the medication LEMTRADA to the VA. The award was not set aside and is for delivery to the VA medical facility in Pittsburgh, PA. Walgreens Specialty Pharmacy, LLC is the prime contractor and no subcontractors are mentioned. The contract has an ultimate completion date of February 17, 2017.
Generated 4/2/25, 4:18 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($23k) | 2/13/17 | |
| Not listed | Not listed | $98.8k | 1/12/17 |